Targeting Stat3 With G-Quartet Oligonucleotides in Metastatic Prostate Cancer
Annual rept. 1 Apr 2003-31 Mar 2004
BAYLOR COLL OF MEDICINE HOUSTON TX
Pagination or Media Count:
This annual report is composed of 1 introduction of the goal of this project and specific aims, 2 research accomplishments by PT group from 4103 to 33104 including one publication and one manuscript, 3 summary of results and significance, and 4 conclusion of the project studies. This report demonstrated that during the period from 4103 to 33104, PT group made a significant progress in developing a novel and potent anti-cancer agent, which holds promise or the systemic treatment of prostate cancer.
- Anatomy and Physiology
- Medicine and Medical Research